BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123685
Published online Jan 21, 2027. doi: 10.3748/wjg.123685
Figure 1
Figure 1 Study flowchart of patient recruitment and the research workflow. GIST: Gastrointestinal stromal tumors; CT: Computed tomography; LASSO: Least absolute shrinkage and selection operator.
Figure 2
Figure 2 Variable selection using least absolute shrinkage and selection operator regression analysis. A: Least absolute shrinkage and selection operator coefficient profiles of the variables; B: Selection of the optimal tuning parameter (λ) in the least absolute shrinkage and selection operator model via 10-fold cross-validation.
Figure 3
Figure 3 Visualized nomogram for predicting recurrence-free survival in patients with gastrointestinal stromal tumors. EFDV: Enlarged feeding or draining vessels; RFS: Recurrence-free survival.
Figure 4
Figure 4 Time-dependent areas under the curve of the training set and validation set. A: Training set; B: Validation set. AUC: Areas under the curve; CI: Confidence interval; RFS: Recurrence-free survival.
Figure 5
Figure 5 Calibration curves in the training and validation cohorts demonstrated excellent agreement between predicted and observed recurrence-free survival rates at 1-year, 3-years, and 5-years. A: Training set; B: Validation set.
Figure 6
Figure 6 Decision curve analysis for predicting 1-year, 3-year, and 5-year recurrence in the training cohort and the validation cohorts. A: Training cohort, 1-year recurrence; B: Training cohort, 3-year recurrence; C: Training cohort, 5-year recurrence; D: Validation cohort, 1-year recurrence; E: Validation cohort, 3-year recurrence; F: Validation cohort, 5-year recurrence.


Write to the Help Desk